Impact of Fatigue on Work Productivity, Activity Impairment, and Healthcare Resource Utilization in Inflammatory Bowel Disease
Fatigue is associated with an increase in HCU only in the setting of concomitantly active disease. On the other hand, fatigue is associated with a negative impact on WPAI in the setting of both active and inactive disease.
Authors
- Linda A. Feagins (ORCID: https://orcid.org/0000-0001-7758-3257)
- Melissa Eliot (ORCID: https://orcid.org/0000-0003-3280-935X)
- Jill Gaidos (ORCID: https://orcid.org/0000-0002-1240-1819)
- Page C. Moore (ORCID: https://orcid.org/0000-0002-3428-8781)
- Anita M. Loughlin (ORCID: https://orcid.org/0000-0002-3115-3021)
- Margaux M. Crabtree
- Celeste A. Lemay
Institutions
- Yale University (US)
- Navitas Systems (United States) (US)
- The University of Texas at Austin (US)
Publication Details
- Journal
- Crohn s & Colitis 360
- Published
- 2024-12-21
- DOI
- https://doi.org/10.1093/crocol/otae073
- Citations
- 4
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 2.20
Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Novartis
- AbbVie
- Boehringer Ingelheim
- Ortho Dermatologics
- Australian Renewable Energy Agency
- LEO Pharma
- Genentech
- Bristol-Myers Squibb Canada
- Chugai Pharmaceutical
- Janssen Pharmaceuticals